Mirae Asset Global Etfs Holdings Ltd. Spring Works Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 43,082 shares of SWTX stock, worth $1.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,082
Previous 40,036
7.61%
Holding current value
$1.8 Million
Previous $1.51 Million
8.49%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SWTX
# of Institutions
238Shares Held
69.8MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$280 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$234 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$160 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$147 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$143 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.6B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...